Welcome again to the Reflections Dyslipidemia Global Newsletter, where an international Scientific Planning Committee summarizes and provides expert commentary on the latest clinical and real-world evidence in the field of dyslipidemia. These articles are chosen based on their significance to every day clinical practice.

This newsletter focuses on recent updates to risk assessment with lipoprotein(a), the earlier role of combination therapy, and several articles on special populations such as young adults, familial hypercholesterolemia, obesity, and people with diabetes.

As with the previous newsletters, we invite you to interact through links to short video commentaries from our SPC, links to videos or podcasts, along with hyperlinks to full articles for in-depth study and reflection.

Prof. Farnier (Chair)

Key articles in Newsletter #7: